We recently published a list of 10 Best DRIP Stocks To Own Now. In this article, we are going to take a look at where Johnson ...

Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...

Johnson & Johnson (NYSE:JNJ) is reportedly suing Samsung Bioepis for breach of contract related to the launch of a biosimilar ...

Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenues beat the same driven ...

A higher dividend yield is nice because it allows you to collect more dividend income on every dollar you invest in a stock.

Simplify’s Managed Futures Strategy ETF focuses on commodities and bonds. Read how CTA could fit and perform in an investment ...

Mizuho analyst Graig Suvannavejh downgraded Intra-Cellular (ITCI) to Neutral from Outperform with a price target of $132, down from $140, ...

Swiss generics and biosimilars major Sandoz has announced the launch of Pyzchiva (ustekinumab-ttwe) in the USA. From today, ...

Hartford Equity Income Fund (I share) underperformed the Russell 1000 Value Index during the quarter. Read more here.

Monday was another volatile session for US stock markets, with equities finishing mostly lower after a late-afternoon ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...